Frequently Asked Questions

GLP-1 receptor agonists are a class of FDA-approved medications that influence appetite, satiety, and gastric emptying. In clinical trials, they have shown clinically meaningful weight-loss outcomes for many patients when prescribed appropriately and combined with lifestyle support. Whether they are right for any individual is a medical decision a licensed clinician makes during evaluation.

BridgeWell is designed for adults seeking a structured, supported, evaluation-first approach to medically supervised weight management. Many members are evaluated for GLP-1 therapy by a licensed clinician at our independent clinical partner; treatment is prescribed only when clinically appropriate. Members who don't meet the medical criteria still get the BridgeWell nutrition, coaching, and movement support layer.

A board-certified clinician at our clinical partner. BridgeWell coordinates your overall experience but does not prescribe — the medical intake review and prescribing decision are made by the clinical partner clinician.

No. The clinical partner runs a 100% telehealth practice for the medical track; BridgeWell hosts your coaching, nutrition, movement, and progress tracking inside the same app, also fully online.

Three: BridgeWell Start, BridgeWell Full, and BridgeWell Maintain. Every plan is scoped to a specific lifecycle stage.

Taper is a lifecycle phase within BridgeWell Maintain — a clinician-partner-supervised dose-reduction protocol with intensified BridgeWell coaching and a safety gate that pauses if weight rebounds. It is not a separate commercial plan.

Yes. Plan transitions are seamless and typically happen when the clinical partner clinician and your BridgeWell coach agree the lifecycle phase fits.

Just the one-time $39.00 BridgeWell enrollment fee. That covers your BridgeWell program enrollment, care-team match, profile setup, and orientation. Clinical visits, prescription, and pharmacy fulfillment are billed separately by our clinical partner.

Your clinical partner clinician. The specific medication options, formats, and dosing protocols are explained during their clinical review. BridgeWell does not direct prescribing.

No. Clinical services and medication are billed by our clinical partner. BridgeWell's only charge is the one-time enrollment fee.

Published clinical-trial data shows that, on average, patients regain up to two-thirds of lost weight within one year of stopping GLP-1 medication without structured support. BridgeWell's Maintain plan and Taper phase are designed to address this risk through clinician-supervised tapering and ongoing nutrition, coaching, and movement support — though individual results vary.

As long as it's useful. Many members use Maintain indefinitely as a long-term metabolic health membership — with ongoing coaching, nutrition support, and relapse monitoring.

Yes. BridgeWell is built with HIPAA-conscious architecture: role-based access, full audit trails, secure messaging, and clean separation of clinical and operational data.

No. Even under employer-sponsored plans, individual health data is never shared with employers. Employers receive aggregate outcome reporting only.